US4811731A
(en)
*
|
1985-07-30 |
1989-03-14 |
Glaxo Group Limited |
Devices for administering medicaments to patients
|
IT1222509B
(it)
*
|
1987-08-17 |
1990-09-05 |
Miat Spa |
Insufflatore per la somministrazione di farmaci sotto forma di polvere predosata in opercoli
|
US4817789A
(en)
*
|
1987-09-23 |
1989-04-04 |
Allergan, Inc. |
Lens container assembly
|
FR2626500B1
(fr)
*
|
1988-01-28 |
1990-04-27 |
Valois Sa |
Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
|
CH678151A5
(en)
*
|
1988-07-13 |
1991-08-15 |
Heinz Hermann Weick |
Self-medication nasal dispenser
|
GB8824804D0
(en)
*
|
1988-10-22 |
1988-11-30 |
Fisons Plc |
Device
|
SE466684B
(sv)
*
|
1989-03-07 |
1992-03-23 |
Draco Ab |
Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
|
US5176132A
(en)
*
|
1989-05-31 |
1993-01-05 |
Fisons Plc |
Medicament inhalation device and formulation
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
IT1230313B
(it)
*
|
1989-07-07 |
1991-10-18 |
Somova Spa |
Inalatore per medicamenti in capsule.
|
DE3927170A1
(de)
*
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
US5208226A
(en)
*
|
1989-09-08 |
1993-05-04 |
Glaxo Group Limited |
Medicaments
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
DK544589D0
(da)
*
|
1989-11-01 |
1989-11-01 |
Novo Nordisk As |
Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof
|
YU48707B
(sh)
|
1990-03-02 |
1999-07-28 |
Glaxo Group Limited |
Aparat za inhaliranje - inhalator
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280967B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
GB9012870D0
(en)
*
|
1990-06-08 |
1990-08-01 |
Glaxo Group Ltd |
Device
|
GB9015522D0
(en)
*
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
IT1243344B
(it)
*
|
1990-07-16 |
1994-06-10 |
Promo Pack Sa |
Inalatore plurimonodose per medicamenti in polvere
|
SE9002895D0
(sv)
*
|
1990-09-12 |
1990-09-12 |
Astra Ab |
Inhalation devices for dispensing powders i
|
US5429122A
(en)
*
|
1990-09-26 |
1995-07-04 |
Zanen; Pieter |
Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
NL9002706A
(nl)
*
|
1990-12-10 |
1992-07-01 |
Pharmachemie Bv |
Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
DE69233690T2
(de)
*
|
1991-07-02 |
2008-01-24 |
Nektar Therapeutics, San Carlos |
Abgabevorrichtung für nebelförmige Medikamente
|
US5337740A
(en)
*
|
1991-08-01 |
1994-08-16 |
New England Pharmaceuticals, Inc. |
Inhalation devices
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US5287850A
(en)
*
|
1991-08-20 |
1994-02-22 |
Habley Medical Technology Corporation |
Timing and velocity controlled powered pharmaceutical inhaler
|
DE4128295A1
(de)
*
|
1991-08-27 |
1993-03-04 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung fuer fliessfaehige medien
|
GB9124468D0
(en)
*
|
1991-11-18 |
1992-01-08 |
Smithkline Beecham Plc |
Novel device
|
DE4211475A1
(de)
*
|
1991-12-14 |
1993-06-17 |
Asta Medica Ag |
Pulverinhalator
|
GB2264237A
(en)
*
|
1992-02-05 |
1993-08-25 |
Robert Edward Newell |
An inhaler
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
EP0558879B1
(en)
*
|
1992-03-04 |
1997-05-14 |
Astra Aktiebolag |
Disposable inhaler
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
JPH0633935Y2
(ja)
*
|
1992-03-27 |
1994-09-07 |
サカセ化学工業株式会社 |
グルーピングメディシンプール
|
ATE158951T1
(de)
*
|
1992-05-29 |
1997-10-15 |
Ggu Gesundheits Umweltforsch |
Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US5785049A
(en)
*
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
NZ262807A
(en)
*
|
1993-03-03 |
1997-11-24 |
Glaxo Wellcome Inc |
Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
US5372128A
(en)
*
|
1993-04-14 |
1994-12-13 |
Habley Medical Technology Corporation |
Fluidizing powder inhaler
|
US5533502A
(en)
*
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
BE1007408A3
(nl)
*
|
1993-08-13 |
1995-06-06 |
Winters Joep |
Werkwijze en inrichting voor het controleren van het gebruik van een geneesmiddel.
|
US5524613A
(en)
*
|
1993-08-25 |
1996-06-11 |
Habley Medical Technology Corporation |
Controlled multi-pharmaceutical inhaler
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
KR100419037B1
(ko)
|
1994-03-07 |
2004-06-12 |
넥타르 테라퓨틱스 |
폐를통한인슐린의전달방법및그조성물
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
CN1073119C
(zh)
*
|
1994-05-18 |
2001-10-17 |
吸入治疗系统公司 |
干扰素干粉配方的方法及组合物
|
US5483954A
(en)
*
|
1994-06-10 |
1996-01-16 |
Mecikalski; Mark B. |
Inhaler and medicated package
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
CN1131080C
(zh)
|
1994-09-21 |
2003-12-17 |
吸入治疗系统 |
用于喷洒干的粉末药物的方法和装置
|
FR2725626A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
US5676643A
(en)
*
|
1995-02-13 |
1997-10-14 |
The Procter & Gamble Company |
Dispenser for friably releasing dry particulate medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
NL1001031C1
(nl)
*
|
1995-08-23 |
1997-02-25 |
Npk Ind Design B V |
Inrichting voor het afgeven van pillen uit een blisterverpakking.
|
US5649554A
(en)
*
|
1995-10-16 |
1997-07-22 |
Philip Morris Incorporated |
Electrical lighter with a rotatable tobacco supply
|
US5827985A
(en)
*
|
1995-12-19 |
1998-10-27 |
Endress + Hauser Gmbh + Co. |
Sensor apparatus for process measurement
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
TR199801265T2
(xx)
|
1996-01-03 |
1998-10-21 |
Glaxo Group Limited |
��e soluma cihaz�.
|
USD381416S
(en)
*
|
1996-02-08 |
1997-07-22 |
Astra Aktiebolag |
Unit dose inhaler
|
US5743251A
(en)
|
1996-05-15 |
1998-04-28 |
Philip Morris Incorporated |
Aerosol and a method and apparatus for generating an aerosol
|
GB9610821D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
GB9616047D0
(en)
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5976574A
(en)
|
1996-12-31 |
1999-11-02 |
Inhale Therapeutic Systems |
Processes for spray drying hydrophobic drugs in organic solvent suspensions
|
US5794613A
(en)
*
|
1997-01-09 |
1998-08-18 |
Sepracor, Inc. |
Multiple-dose dispenser for dry powder inhalers
|
TW469832U
(en)
*
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6237590B1
(en)
*
|
1997-09-18 |
2001-05-29 |
Delsys Pharmaceutical Corporation |
Dry powder delivery system apparatus
|
USD417731S
(en)
*
|
1997-10-22 |
1999-12-14 |
The Procter & Gamble Company |
Container for nasal spray
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CN1301185A
(zh)
*
|
1997-12-02 |
2001-06-27 |
杜兰药品公司 |
干粉吸入器
|
IL138153A0
(en)
|
1998-03-16 |
2001-10-31 |
Inhale Therapeutic Syst |
Methods and devices for delivering aerosolized active agents
|
DE19817417A1
(de)
*
|
1998-04-18 |
1999-10-21 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien, insbesondere Pulver
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
*
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
KR100522910B1
(ko)
*
|
1998-09-15 |
2005-12-21 |
주식회사 새 한 |
청량감이 우수한 폴리에스테르 가연가공사의 제조방법
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6234167B1
(en)
|
1998-10-14 |
2001-05-22 |
Chrysalis Technologies, Incorporated |
Aerosol generator and methods of making and using an aerosol generator
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
BR0011343A
(pt)
|
1999-06-05 |
2002-03-12 |
Innovata Biomed Ltd |
Dispositivo de distribuição de medicamento,e,métodos de administrar um medicamento por inalação,e de,tratamento de um paciente com distúrbio respiratório
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US6730066B1
(en)
*
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
GB9924415D0
(en)
*
|
1999-10-16 |
1999-12-15 |
Glaxo Group Ltd |
Medicament pack
|
WO2001034234A1
(en)
*
|
1999-11-11 |
2001-05-17 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6810872B1
(en)
|
1999-12-10 |
2004-11-02 |
Unisia Jecs Corporation |
Inhalant medicator
|
US20010029947A1
(en)
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US6883516B2
(en)
*
|
2000-04-27 |
2005-04-26 |
Chrysalis Technologies Incorporated |
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
|
MY136453A
(en)
*
|
2000-04-27 |
2008-10-31 |
Philip Morris Usa Inc |
"improved method and apparatus for generating an aerosol"
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
TWI224515B
(en)
*
|
2000-06-23 |
2004-12-01 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
EP1172122A1
(en)
*
|
2000-07-14 |
2002-01-16 |
The Technology Partnership Public Limited Company |
Dry powder inhaler
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
OA12394A
(en)
|
2000-08-05 |
2004-07-09 |
Glaxo Group Ltd |
6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
|
JP2004505730A
(ja)
*
|
2000-08-15 |
2004-02-26 |
ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション |
プログラム可能多用量鼻腔内薬物送達デバイス
|
SE517229C2
(sv)
*
|
2000-09-25 |
2002-05-14 |
Microdrug Ag |
Kontinuerlig inhalator för torrt pulver
|
GB0023654D0
(en)
|
2000-09-27 |
2000-11-08 |
Cambridge Consultants |
Device for administering doses of particulate material
|
US6595210B2
(en)
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
US6701921B2
(en)
*
|
2000-12-22 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater in multilayered composite and method of use thereof
|
US6501052B2
(en)
|
2000-12-22 |
2002-12-31 |
Chrysalis Technologies Incorporated |
Aerosol generator having multiple heating zones and methods of use thereof
|
US6491233B2
(en)
|
2000-12-22 |
2002-12-10 |
Chrysalis Technologies Incorporated |
Vapor driven aerosol generator and method of use thereof
|
US6681998B2
(en)
|
2000-12-22 |
2004-01-27 |
Chrysalis Technologies Incorporated |
Aerosol generator having inductive heater and method of use thereof
|
US6799572B2
(en)
|
2000-12-22 |
2004-10-05 |
Chrysalis Technologies Incorporated |
Disposable aerosol generator system and methods for administering the aerosol
|
US7077130B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Chrysalis Technologies Incorporated |
Disposable inhaler system
|
EP1359902B1
(en)
*
|
2001-02-06 |
2007-08-08 |
Innovata Biomed Limited |
Bimodal dry powder formulation for inhalation
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
EP1381417A4
(en)
|
2001-04-26 |
2009-12-30 |
New England Pharm Inc |
DEVICE FOR RELEASING SATISFIED DOSHES OF LIQUID AND POWDERY MEDIUM
|
EP2039700A2
(en)
|
2001-04-30 |
2009-03-25 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
US8061006B2
(en)
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
US6540081B2
(en)
*
|
2001-09-06 |
2003-04-01 |
Ecolab Inc. |
Unit dose blister pack product dispenser
|
PT1425001E
(pt)
|
2001-09-14 |
2009-02-18 |
Glaxo Group Ltd |
Derivados de fenetanolamina para o tratamento de doenças respiratórias
|
EP1487417A4
(en)
|
2001-09-17 |
2010-03-17 |
Glaxo Group Ltd |
DRY POWDER DRUG FORMULATIONS
|
CN1313171C
(zh)
|
2001-09-19 |
2007-05-02 |
埃德文特药物有限公司 |
吸入器
|
US6640050B2
(en)
|
2001-09-21 |
2003-10-28 |
Chrysalis Technologies Incorporated |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US6568390B2
(en)
|
2001-09-21 |
2003-05-27 |
Chrysalis Technologies Incorporated |
Dual capillary fluid vaporizing device
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
US20030094173A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Inhale Therapeutic Systems, Inc. |
Aerosolization device with improved endpiece connection
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US6681769B2
(en)
|
2001-12-06 |
2004-01-27 |
Crysalis Technologies Incorporated |
Aerosol generator having a multiple path heater arrangement and method of use thereof
|
US6804458B2
(en)
*
|
2001-12-06 |
2004-10-12 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
|
US20030168057A1
(en)
*
|
2001-12-14 |
2003-09-11 |
Inhale Therapeutic Systems, Inc. |
Electronically controllable aerosol delivery
|
US6701922B2
(en)
|
2001-12-20 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Mouthpiece entrainment airflow control for aerosol generators
|
US7458373B2
(en)
*
|
2002-01-15 |
2008-12-02 |
Philip Morris Usa Inc. |
Aerosol generator for drug formulation
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1467790A1
(en)
*
|
2002-01-25 |
2004-10-20 |
Glaxo Group Limited |
Medicament dispenser
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
CA2477604A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
JP2006504446A
(ja)
*
|
2002-03-26 |
2006-02-09 |
グラクソ グループ リミテッド |
ラミネート・アセンブリーの形成方法、およびそれにより形成される製品
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US7271197B2
(en)
*
|
2002-04-25 |
2007-09-18 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
WO2003091679A1
(en)
*
|
2002-04-25 |
2003-11-06 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003095005A1
(en)
*
|
2002-05-10 |
2003-11-20 |
Chrysalis Technologies Incorporated |
Aerosol generator for drug formulation and methods of generating aerosol
|
AU2003269872A1
(en)
*
|
2002-05-15 |
2003-12-31 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
US7185651B2
(en)
*
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
ES2278170T3
(es)
|
2002-07-09 |
2007-08-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
|
DE10230751A1
(de)
|
2002-07-09 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003250166A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Glaxo Group Limited |
Medicament dispenser
|
AU2003254590A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
ATE491521T1
(de)
*
|
2002-09-06 |
2011-01-15 |
Philip Morris Usa Inc |
Aerosolerzeugungsvorrichtungen und verfahren zur erzeugung von aerosolen mit gesteuerten teilchengrössen
|
AU2003270602A1
(en)
*
|
2002-09-13 |
2004-04-30 |
Glaxo Group Limited |
Coated blending system
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
EP1554264B1
(en)
*
|
2002-10-22 |
2007-08-08 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
US6772757B2
(en)
|
2002-10-25 |
2004-08-10 |
Chrysalis Technologies Incorporated |
Concentric controlled temperature profile fluid vaporizing device
|
AU2003286143A1
(en)
|
2002-10-28 |
2004-05-13 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
WO2004060260A2
(en)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US6941947B2
(en)
*
|
2002-12-18 |
2005-09-13 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
EP1587482A4
(en)
*
|
2003-01-31 |
2010-08-25 |
Technion Res & Dev Foundation |
ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF
|
JP2006517215A
(ja)
*
|
2003-02-11 |
2006-07-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン薬と可溶性tnf受容体融合タンパク質とを基にした新規な医薬組成物
|
WO2004071527A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
US20040245279A1
(en)
*
|
2003-05-05 |
2004-12-09 |
Bradley Tareasa L. |
System for dispensing an active ingredient using a dispensable tablet, dispensable tablet and container for holding such dispensable tablets
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
EP1488819A1
(en)
*
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Dry powder inhaler and method for pulmonary inhalation of dry powder
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
TW200519108A
(en)
|
2003-07-17 |
2005-06-16 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
JP2007500151A
(ja)
|
2003-07-29 |
2007-01-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベータ受容体刺激薬及び抗コリン薬を含む吸入用医薬
|
US7367334B2
(en)
|
2003-08-27 |
2008-05-06 |
Philip Morris Usa Inc. |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US6991131B2
(en)
*
|
2003-09-02 |
2006-01-31 |
Ecolab, Inc. |
Distributable container and system and method using distributable container
|
AU2004273547B2
(en)
*
|
2003-09-24 |
2006-07-06 |
Tianda Pharmaceuticals (Australia) Pty Ltd |
Medication holder
|
NZ546730A
(en)
|
2003-09-24 |
2008-04-30 |
Medi Stream Pty Ltd |
Medication holder
|
EA013689B1
(ru)
|
2003-10-14 |
2010-06-30 |
Глэксо Груп Лимитед |
Антагонисты мускариновых ацетилхолиновых рецепторов
|
MXPA06004242A
(es)
|
2003-10-17 |
2006-06-28 |
Glaxo Group Ltd |
Antagonistas del receptor muscarinico de la acetilcolina.
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
WO2005044173A1
(en)
*
|
2003-10-27 |
2005-05-19 |
Oriel Therapeutics, Inc. |
Blister packages and associated methods of fabricating dry powder drug containment systems
|
CA2543482A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
SG149876A1
(en)
|
2003-11-03 |
2009-02-27 |
Boehringer Ingelheim Int |
Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
|
SG137859A1
(en)
|
2003-11-03 |
2007-12-28 |
Boehringer Ingelheim Int |
Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
|
GB0325627D0
(en)
*
|
2003-11-03 |
2003-12-10 |
Glaxo Group Ltd |
A hand-held capsule device
|
PE20050489A1
(es)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
GB0329182D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
EP1725564A4
(en)
|
2004-03-17 |
2007-09-12 |
Glaxo Group Ltd |
ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
|
CA2561400A1
(en)
|
2004-04-02 |
2005-10-13 |
Glaxo Group Limited |
Chemical process and new crystalline form
|
US8851069B2
(en)
*
|
2004-04-21 |
2014-10-07 |
Innovata Biomed Limited |
Inhaler
|
KR101287460B1
(ko)
|
2004-04-22 |
2013-07-23 |
베링거 인겔하임 인터내셔날 게엠베하 |
벤즈옥사진을 함유하는 호흡기 질환 치료용 약제학적배합물
|
US20050272726A1
(en)
*
|
2004-04-22 |
2005-12-08 |
Boehringer Ingelheim International Gmbh |
Novel medicaments for the treatment of respiratory diseases
|
US7861712B2
(en)
|
2004-04-23 |
2011-01-04 |
Manta Product Development |
Sealed capsule including an integrated puncturing mechanism
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
US7611709B2
(en)
*
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7727962B2
(en)
*
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7723306B2
(en)
*
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7598267B2
(en)
|
2004-05-13 |
2009-10-06 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
US20050256115A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Aerosol formulation for the inhalation of beta-agonists
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
WO2005110519A1
(en)
*
|
2004-05-17 |
2005-11-24 |
Sun Pharmaceutical Industries Limited |
Dry powder inhaler
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
US7896195B2
(en)
*
|
2004-06-08 |
2011-03-01 |
Ecolab Inc. |
Tablet dispenser with isolated product hopper
|
US20050283106A1
(en)
*
|
2004-06-17 |
2005-12-22 |
Shane Smith |
Reusable support device with therapeutic inserts
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
GB0418278D0
(en)
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
CA2575692C
(en)
|
2004-08-20 |
2014-10-14 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
GB0418738D0
(en)
*
|
2004-08-23 |
2004-09-22 |
3M Innovative Properties Co |
Medicinal aerosol formulation receptacle and production thereof
|
BR122019022692B1
(pt)
|
2004-08-23 |
2023-01-10 |
Mannkind Corporation |
Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
|
WO2006047663A2
(en)
*
|
2004-10-26 |
2006-05-04 |
The University Of North Carolina At Chapel Hill |
Aerosol generation of therapeutic agents
|
JP2006130143A
(ja)
*
|
2004-11-08 |
2006-05-25 |
Hitachi Ltd |
吸入式投薬器及び薬剤カートリッジ
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
US20080042823A1
(en)
*
|
2004-11-12 |
2008-02-21 |
Heasley Matthew G |
Sensor System with Acoustic Transducer
|
ES2704482T3
(es)
|
2004-11-24 |
2019-03-18 |
Meda Pharmaceuticals Inc |
Composiciones que comprenden azelastina y sus métodos de uso
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
US20080125462A1
(en)
*
|
2005-01-11 |
2008-05-29 |
Lois Elizabeth Vernon |
Cinnamate Salts Of A Beta-2 Adrenergic Agonist
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8221804B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
MX2007009656A
(es)
|
2005-02-10 |
2007-11-07 |
Glaxo Group Ltd |
Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma.
|
EP1858528A2
(en)
*
|
2005-02-10 |
2007-11-28 |
Glaxo Group Limited |
Process for crystallizing lactose particles for use in pharmaceutical formulations
|
TW200724142A
(en)
|
2005-03-25 |
2007-07-01 |
Glaxo Group Ltd |
Novel compounds
|
PE20061351A1
(es)
|
2005-03-25 |
2007-01-14 |
Glaxo Group Ltd |
COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
|
GB0507711D0
(en)
|
2005-04-15 |
2005-05-25 |
Vectura Group Plc |
Improved blister piercing
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
US8653028B2
(en)
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
CN101166738B
(zh)
|
2005-05-02 |
2011-06-01 |
贝林格尔·英格海姆国际有限公司 |
噻托溴铵的新晶型
|
US8546423B2
(en)
*
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
PT1901749T
(pt)
|
2005-05-18 |
2016-11-04 |
Raptor Pharmaceuticals Inc |
Fluoroquinolonas aerossolizadas e suas utilizações
|
EP1898894A1
(en)
*
|
2005-06-17 |
2008-03-19 |
Boehringer Ingelheim International GmbH |
Mrp iv inhibitors for the treatment of respiratory diseases
|
DE102005030733A1
(de)
|
2005-07-01 |
2007-01-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US20070012316A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Joann Truza |
Disposable compact rescue inhaler
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
GB0515584D0
(en)
*
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
KR101360803B1
(ko)
*
|
2005-08-15 |
2014-02-11 |
베링거 인겔하임 인터내셔날 게엠베하 |
베타모방제의 제조방법
|
US7767691B2
(en)
|
2005-08-18 |
2010-08-03 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
US20130131007A1
(en)
|
2005-09-07 |
2013-05-23 |
Bebaas, Inc. |
Vitamin b12 compositions
|
US20070178141A1
(en)
*
|
2005-09-07 |
2007-08-02 |
Bebaas, Inc. |
Vitamin B12 compositions
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US7481331B2
(en)
*
|
2005-09-09 |
2009-01-27 |
Manrex Limited |
Dispensing container for a blister pack of medications
|
HUE028691T2
(en)
|
2005-09-14 |
2016-12-28 |
Mannkind Corp |
A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
|
TWI396541B
(zh)
|
2005-10-10 |
2013-05-21 |
Boehringer Ingelheim Int |
用於治療呼吸疾病之新穎藥物組合
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
DE102005057685A1
(de)
*
|
2005-12-01 |
2007-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
AR058289A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
DE102005059602A1
(de)
|
2005-12-14 |
2007-06-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Mikronisierung
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
EP1993645A4
(en)
*
|
2006-03-03 |
2011-05-18 |
Stc Unm |
DRY POWDER INHALER WITH AEROELASTIC SPREADING MECHANISM
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
DE102006016904A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
EP1844805A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Inhalator
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
PT103481B
(pt)
|
2006-05-16 |
2008-08-01 |
Hovione Farmaciencia S A |
Inalador de uso simples e método de inalação
|
EP2032664B1
(en)
|
2006-05-19 |
2017-11-08 |
Valspar Sourcing, Inc. |
Coating system for cement composite articles
|
WO2008008021A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Astrazeneca Ab |
Inhalation system and delivery device for the administration of a drug in the form of dry powder.
|
WO2008017637A1
(de)
|
2006-08-07 |
2008-02-14 |
Boehringer Ingelheim International Gmbh |
Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
|
UY30552A1
(es)
*
|
2006-08-22 |
2008-03-31 |
Boehringer Ingelheim Int |
Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
|
DE102006045788A1
(de)
*
|
2006-09-26 |
2008-03-27 |
Alfred Von Schuckmann |
Spender für pulverförmige Massen
|
US8573197B2
(en)
*
|
2006-10-25 |
2013-11-05 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
GB0622827D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
CA2689296C
(en)
|
2007-01-10 |
2015-11-17 |
Purdue Research Foundation |
Polypeptide inhibitors of hsp27 kinase and uses therefor
|
US8741849B2
(en)
*
|
2007-01-10 |
2014-06-03 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
US20080237082A1
(en)
*
|
2007-03-29 |
2008-10-02 |
R. P. Scherer Technologies, Inc. |
Child resistant device for housing blister packs
|
AT505246B8
(de)
*
|
2007-06-01 |
2009-06-15 |
Croma Pharma Gmbh |
Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
|
US11224704B2
(en)
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
EP3453418A1
(en)
|
2007-07-06 |
2019-03-13 |
Manta Devices, LLC |
Delivery device and related methods
|
EP2093219A1
(de)
|
2008-02-22 |
2009-08-26 |
Boehringer Ingelheim International Gmbh |
Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
|
MX2010010050A
(es)
|
2008-03-20 |
2011-03-15 |
Virun Inc Star |
Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
|
EP2268274B1
(en)
|
2008-03-20 |
2012-05-16 |
Virun, Inc. |
Vitamin e derivatives and their uses
|
KR20110028457A
(ko)
*
|
2008-05-21 |
2011-03-18 |
뉴로테즈 인코포레이티드 |
신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
AR072114A1
(es)
|
2008-06-13 |
2010-08-04 |
Mannkind Corp |
Un inhalador de polvo seco y sistema para suministro de farmacos
|
BRPI0914308B8
(pt)
|
2008-06-20 |
2021-06-22 |
Mannkind Corp |
sistema de inalação
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
JP5339794B2
(ja)
*
|
2008-07-04 |
2013-11-13 |
キヤノン株式会社 |
吸入装置
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
SI2346556T1
(sl)
|
2008-09-26 |
2015-02-27 |
Oriel Therapeutics, Inc. |
Inhalatorji za suhi prah z elementi za dvojno prebadanje in z njimi povezane naprave in postopki
|
ES2570128T3
(es)
|
2008-09-26 |
2016-05-17 |
Oriel Therapeutics Inc |
Inhaladores con discos que tienen conductos de aire equipados con canales discretos de conductos de aire y discos y métodos relacionados
|
EP2346554B1
(en)
*
|
2008-09-26 |
2015-09-16 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
US9050427B2
(en)
*
|
2008-09-30 |
2015-06-09 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
ES2561899T3
(es)
*
|
2008-10-01 |
2016-03-01 |
Oriel Therapeutics, Inc. |
Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
|
HUE050147T2
(hu)
*
|
2008-10-07 |
2020-11-30 |
Horizon Orphan Llc |
Tüdõgyulladás csökkentése levofloxacin belélegzése útján
|
MX345158B
(es)
|
2008-10-07 |
2017-01-18 |
Raptor Pharmaceuticals Inc |
Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
|
JP5785085B2
(ja)
*
|
2008-10-20 |
2015-09-24 |
モイライ マトリックス インコーポレイテッド |
癒着を処置又は防止するためのポリペプチド
|
CA2742600A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
CA2744104C
(en)
*
|
2008-12-10 |
2017-07-18 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US8550074B2
(en)
*
|
2009-01-15 |
2013-10-08 |
Manta Devices, Llc |
Delivery device and related methods
|
GB0901520D0
(en)
*
|
2009-01-30 |
2009-03-11 |
Vectura Delivery Devices Ltd |
Inhaler
|
CN104523661A
(zh)
*
|
2009-02-06 |
2015-04-22 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
WO2010089391A1
(en)
|
2009-02-09 |
2010-08-12 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
PL2400950T3
(pl)
|
2009-02-26 |
2019-12-31 |
Glaxo Group Limited |
Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
PE20120647A1
(es)
*
|
2009-03-13 |
2012-05-31 |
Nucitec Sa De Cv |
Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
|
CA2992927A1
(en)
|
2009-03-18 |
2010-09-23 |
Mannkind Corporation |
Inhaler adaptor for a laser diffraction apparatus and method for measuring particle size distribution
|
KR101875969B1
(ko)
|
2009-06-12 |
2018-07-06 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
AR077101A1
(es)
|
2009-06-16 |
2011-08-03 |
Schering Corp |
Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
|
JP2012532191A
(ja)
|
2009-07-06 |
2012-12-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
[4,6−ビス(ジメチルアミノ)−2−(4−{[4−(トリフルオロメチル)ベンゾイル]アミノ}ベンジル)ピリミジン−5−イル]の多形体
|
SI2453894T1
(sl)
|
2009-07-15 |
2016-02-29 |
Theravance Biopharma R&D Ip, Llc |
Kristalinična oblika proste baze bifenilne spojine
|
CN102762573B
(zh)
|
2009-07-24 |
2015-09-16 |
阿马曾提斯公司 |
用于在神经退行性障碍中保护脑部健康的化合物、组合物和方法
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
AU2010289326B2
(en)
|
2009-09-04 |
2015-09-24 |
Horizon Therapeutics U.S. Holding Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
EP2477642A4
(en)
*
|
2009-09-17 |
2013-03-13 |
Mutual Pharmaceutical Co |
METHOD FOR THE TREATMENT OF ASTHMA WITH ANTIVIRUS AGENTS
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
AU2010319328A1
(en)
|
2009-11-12 |
2012-05-31 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
WO2011066147A2
(en)
|
2009-11-24 |
2011-06-03 |
Boehringer Ingelheim International Gmbh |
Novel salt forms of pyrimidin-5-yl acetic acid derivative
|
MX2012006003A
(es)
|
2009-11-24 |
2012-06-19 |
Boehringer Ingelheim Int |
Procedimiento para preparar un polimorfo de la sal de colina de [4,6-bis(dimetilamino)-2-(4-{[4-(trifluorometil)-benzoil]amino}be ncil)pirimidin-5-ilo].
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
CN104744215B
(zh)
|
2010-03-03 |
2019-03-15 |
尼昂克技术公司 |
包含单萜的药物组合物
|
WO2011116293A2
(en)
|
2010-03-19 |
2011-09-22 |
Manta Devices, Llc |
Delivery device and related methods
|
EP2563164B1
(en)
|
2010-03-23 |
2016-06-29 |
Virun, Inc. |
Nanoemulsion including sucrose fatty acid ester
|
USD641076S1
(en)
|
2010-03-26 |
2011-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhaler
|
USD635246S1
(en)
|
2010-03-26 |
2011-03-29 |
Oriel Therapeutics, Inc. |
Dose disk for dry powder inhalers
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
CN110464718A
(zh)
|
2010-08-27 |
2019-11-19 |
尼昂克技术公司 |
包含poh衍生物的药物组合物
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
WO2012028663A1
(en)
|
2010-08-31 |
2012-03-08 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
EP2611422B1
(en)
|
2010-08-31 |
2018-10-31 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
SG190793A1
(en)
|
2010-11-11 |
2013-07-31 |
Agency Science Tech & Res |
Targeting metabolic enzymes in human cancer
|
WO2012078804A1
(en)
|
2010-12-07 |
2012-06-14 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
CN103517892B
(zh)
|
2010-12-17 |
2016-01-27 |
尼昂克技术公司 |
使用异紫苏醇的方法和装置
|
CA2824432C
(en)
|
2011-01-31 |
2021-10-19 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
JP6133270B2
(ja)
|
2011-04-01 |
2017-05-24 |
マンカインド コーポレイション |
薬剤カートリッジのためのブリスター包装
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
KR101862291B1
(ko)
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
AU2012254999B2
(en)
|
2011-05-19 |
2016-02-11 |
Savara, Inc. |
Dry powder vancomycin compositions and associated methods
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US8528569B1
(en)
|
2011-06-28 |
2013-09-10 |
Kyle D. Newton |
Electronic cigarette with liquid reservoir
|
US11103659B2
(en)
|
2011-07-06 |
2021-08-31 |
Manta Devices, Llc |
Delivery device and related methods
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
JP6018640B2
(ja)
|
2011-10-24 |
2016-11-02 |
マンカインド コーポレイション |
疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
SG11201404640YA
(en)
|
2012-02-10 |
2014-09-26 |
Virun Inc |
Beverage compositions containing non-polar compounds
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
US9452218B2
(en)
|
2012-03-09 |
2016-09-27 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
EP2841416A1
(en)
|
2012-04-27 |
2015-03-04 |
Glaxo Group Limited |
Novel compounds
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
US9649454B2
(en)
|
2012-05-03 |
2017-05-16 |
Manta Devices, Llc |
Delivery device and related methods
|
WO2013176638A1
(en)
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
An inhaler comprising a mouthpiece having an improved air channel
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
CN115414384A
(zh)
|
2012-09-04 |
2022-12-02 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
EP2925328A1
(en)
|
2012-11-28 |
2015-10-07 |
Intercept Pharmaceuticals, Inc. |
Treatment of pulmonary disease
|
GB201301192D0
(en)
|
2013-01-23 |
2013-03-06 |
Vectura Delivery Devices Ltd |
A blister piercing element for a dry powder inhaler
|
WO2014144895A1
(en)
|
2013-03-15 |
2014-09-18 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
DK177788B1
(en)
|
2013-07-12 |
2014-07-07 |
Liita Holdings Ltd |
Inhaler
|
AU2014290438B2
(en)
|
2013-07-18 |
2019-11-07 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
AU2014296032A1
(en)
|
2013-07-31 |
2016-03-17 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
EP3044218B1
(en)
|
2013-09-10 |
2020-05-27 |
Board Of Regents Of the University Of Texas System |
Therapeutics targeting truncated adenomatous polyposis coli (apc) proteins
|
US10980273B2
(en)
|
2013-11-12 |
2021-04-20 |
VMR Products, LLC |
Vaporizer, charger and methods of use
|
US10058129B2
(en)
|
2013-12-23 |
2018-08-28 |
Juul Labs, Inc. |
Vaporization device systems and methods
|
CA3132323C
(en)
|
2013-12-23 |
2023-02-07 |
Juul Labs, Inc. |
Vaporization device systems and methods
|
US10076139B2
(en)
|
2013-12-23 |
2018-09-18 |
Juul Labs, Inc. |
Vaporizer apparatus
|
USD769438S1
(en)
*
|
2014-01-08 |
2016-10-18 |
Glaxo Group Limited |
Inhaler device
|
JP7066321B2
(ja)
|
2014-01-10 |
2022-05-13 |
アヴァリン ファーマ インク. |
エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
|
US10709173B2
(en)
|
2014-02-06 |
2020-07-14 |
Juul Labs, Inc. |
Vaporizer apparatus
|
TWI828016B
(zh)
|
2014-02-06 |
2024-01-01 |
美商尤爾實驗室有限公司 |
用於產生可吸入蒸汽之電子裝置及包括該電子裝置之系統及套件
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
WO2015164142A1
(en)
*
|
2014-04-24 |
2015-10-29 |
Questa Corporation |
Multi-size pill splitter and methods
|
US11147936B2
(en)
*
|
2014-05-02 |
2021-10-19 |
Manta Devices, Llc |
Dose delivery device with cover connected to dose chamber seal
|
WO2015173701A2
(en)
|
2014-05-12 |
2015-11-19 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions for treating infectious diseases
|
US10940279B2
(en)
*
|
2014-07-01 |
2021-03-09 |
Jennifer K. Keener |
Aromatherapy device
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
CA2965759C
(en)
|
2014-10-31 |
2023-12-12 |
Glaxosmithkline Intellectual Property Development Limited |
Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
|
AU2015350151A1
(en)
|
2014-11-17 |
2017-06-01 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
EP3229831B1
(en)
|
2014-12-10 |
2020-03-11 |
Hyperstem SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
|
SG11201705559RA
(en)
|
2015-01-08 |
2017-08-30 |
Moerae Matrix Inc |
Formulation of mk2 inhibitor peptides
|
CA3206868A1
(en)
|
2015-01-14 |
2016-07-21 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
AU2016219257B2
(en)
|
2015-02-12 |
2020-06-25 |
University Of Southern California |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
US20160264658A1
(en)
|
2015-03-11 |
2016-09-15 |
Glaxosmithkline Intellectual Property Development Limited |
TSLP Binding Proteins
|
JP2018512401A
(ja)
|
2015-03-12 |
2018-05-17 |
モイライ マトリックス インコーポレイテッド |
Mk2阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用
|
US10179215B2
(en)
|
2015-03-19 |
2019-01-15 |
Altria Client Services Llc |
Vaporizer for vaporizing a constituent of a plant material
|
AU2016201131B2
(en)
*
|
2015-03-30 |
2020-04-02 |
Manrex Limited |
Dispensing container for blister pack of medication
|
US9937154B2
(en)
|
2015-06-10 |
2018-04-10 |
Hackensak University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
AU2016280236B2
(en)
|
2015-06-15 |
2019-02-07 |
Astex Therapeutics Limited |
Nrf2 regulators
|
PE20180799A1
(es)
|
2015-06-15 |
2018-05-09 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de nrf2
|
RU2018101077A
(ru)
|
2015-06-15 |
2019-07-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Регуляторы nrf2
|
US10112948B2
(en)
|
2015-07-06 |
2018-10-30 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
EP3322417B1
(en)
|
2015-07-15 |
2023-08-23 |
The Board of Regents of The University of Texas System |
Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
CN104984448B
(zh)
*
|
2015-07-30 |
2018-05-01 |
中山市美捷时包装制品有限公司 |
一种干粉吸入器
|
CN105013054B
(zh)
*
|
2015-07-30 |
2018-11-09 |
中山市美捷时包装制品有限公司 |
一种多胶囊型干粉吸入装置
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
EP3371167A1
(en)
|
2015-10-06 |
2018-09-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
CN108348470A
(zh)
|
2015-11-18 |
2018-07-31 |
葛兰素史克知识产权第二有限公司 |
利巴韦林的药物组合物
|
CA3011185A1
(en)
|
2016-01-20 |
2017-07-27 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
USD861975S1
(en)
|
2016-02-08 |
2019-10-01 |
Juul Labs, Inc. |
Vaporizer device with cartridges
|
WO2017139675A1
(en)
|
2016-02-11 |
2017-08-17 |
Pax Labs, Inc. |
Securely attaching cartridges for vaporizer devices
|
UA125687C2
(uk)
|
2016-02-11 |
2022-05-18 |
Джуул Лебз, Інк. |
Заповнювальний картридж випарного пристрою та способи його заповнення
|
US11224705B2
(en)
|
2016-02-24 |
2022-01-18 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
MX2018010186A
(es)
|
2016-02-25 |
2019-01-14 |
Juul Labs Inc |
Sistemas de control de dispositivo de vaporacion y metodos.
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
EP3515889A1
(en)
|
2016-09-20 |
2019-07-31 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Trpv4 antagonists
|
JP7106528B2
(ja)
|
2016-09-20 |
2022-07-26 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッド |
Trpv4拮抗薬
|
US10858305B2
(en)
|
2016-11-30 |
2020-12-08 |
Neonc Technologies, Inc. |
Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
|
CN108779108A
(zh)
|
2016-12-06 |
2018-11-09 |
葛兰素史密斯克莱知识产权发展有限公司 |
3-(2,3-二氢-1h-茚-5-基)丙酸衍生物和它们作为nrf2调节剂的用途
|
US10426698B2
(en)
*
|
2016-12-08 |
2019-10-01 |
Breeden Brothers, LLC |
Pill container with cap
|
EP3551620A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
US20200071310A1
(en)
|
2016-12-12 |
2020-03-05 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
JP2020502129A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしての3−オキソ−1,4−ジアゼピニル化合物
|
WO2018109647A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
EP3555078B1
(en)
|
2016-12-14 |
2024-03-27 |
GlaxoSmithKline Intellectual Property Development Limited |
Bisaryl heterocycles as nrf2 activators
|
WO2018109646A1
(en)
|
2016-12-15 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 compounds
|
US11059816B2
(en)
|
2016-12-15 |
2021-07-13 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as NRF2 activators
|
EP3599899A1
(en)
|
2017-03-23 |
2020-02-05 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
EP3615545B1
(en)
|
2017-04-24 |
2021-09-01 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
EP3723764A1
(en)
|
2017-12-11 |
2020-10-21 |
GlaxoSmithKline Intellectual Property Development Ltd |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
JP7133023B2
(ja)
|
2018-01-17 |
2022-09-07 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
Pi4kiiiベータ阻害剤
|
BR112020016074A2
(pt)
|
2018-02-08 |
2020-12-08 |
Neonc Technologies, Inc |
Métodos de permeabilização da barreira hematoencefálica
|
JP2021524469A
(ja)
|
2018-05-23 |
2021-09-13 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのインダン
|
CN112638477B
(zh)
|
2018-07-27 |
2024-01-26 |
共晶制药公司 |
作为流感病毒复制的抑制剂的吡咯并[2,3-b]吡啶衍生物
|
WO2020055858A1
(en)
|
2018-09-10 |
2020-03-19 |
Cocrystal Pharma, Inc. |
Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
|
FI3866778T3
(fi)
|
2018-10-17 |
2023-03-21 |
Cocrystal Pharma Inc |
Influenssa viruksen replikaation estäjien yhdistelmät
|
BR112021009254A2
(pt)
|
2018-11-13 |
2021-08-10 |
Cocrystal Pharma, Inc. |
formulações para produtos terapêuticos para influenza
|
EP3887355A1
(en)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
DE102020100550A1
(de)
*
|
2019-01-14 |
2020-07-16 |
Alfred Von Schuckmann |
Vorrichtung zum Inhalieren pulverförmiger Substanzen, Substanzbehälter für eine solche Vorrichtung sowie Verfahren zum Befüllen einer derartigen Vorrichtung
|
DE102019134285A1
(de)
|
2019-01-15 |
2020-07-16 |
Nuuvera Deutschland GmbH |
Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
|
CN113613665A
(zh)
|
2019-03-14 |
2021-11-05 |
Om药物公司 |
治疗和/或预防哮喘、哮喘恶化、过敏性哮喘和/或与呼吸系统病症相关的微生物群相关的病症的方法
|
CU20210077A7
(es)
|
2019-03-14 |
2022-04-07 |
Om Pharma Sa |
Extractos bacterianos estables como fármacos
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
USD943158S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer cartridge
|
USD943159S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Component for a vaporizer cartridge
|
USD943161S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
USD943160S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
JP2023521116A
(ja)
|
2020-04-10 |
2023-05-23 |
コクリスタル ファーマ,インコーポレイテッド |
ノロウイルス及びコロナウイルス複製の阻害剤
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
CA3214507A1
(en)
|
2021-04-14 |
2022-10-20 |
Anthony James Hickey |
Hot porous-solid metering systems and methods for generation of therapeutic aerosols by evaporation/condensation
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
CN118103351A
(zh)
|
2021-08-03 |
2024-05-28 |
共晶制药公司 |
冠状病毒抑制剂
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
WO2023205389A1
(en)
|
2022-04-22 |
2023-10-26 |
Quench Medical Inc. |
Dry powder inhalation delivery of pharmaceuticals
|
WO2023232976A1
(en)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
|
WO2024095105A1
(de)
*
|
2022-11-04 |
2024-05-10 |
Skietta Ag |
Vaporizer zur verdampfung eines inhalationsmediums
|